Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1995, 658-660, Vol 33, No. 3
M Takada, T Suzutani, I Yoshida, M Matoba and M Azuma
We established a method of identifying varicella-zoster virus (VZV)
strains, especially those of the Oka vaccine, in patients with clinical VZV
infections. The DNAs of 30 clinically isolated strains and 4 laboratory
strains including the Oka vaccine strain and its parent VZV strain, were
analyzed by PCR with four sets of primers for the four variable regions,
R2, R4, R5, and a region without a PstI site (PS). R4 was unstable in four
laboratory VZV strains and was excluded from the study. The other regions
were stable in several passages in cell culture. The number of copies in R2
and R5 were distributed from 2 to 13 and from 1 to 3, respectively, in the
strains analyzed. The vaccine strain had seven copies in R2 and two copies
in R5, and it was PS negative. Among 30 clinical isolates, 3, 23, and 11
strains had the same characteristics as the vaccine strain in R2, R5, and
PS, respectively. Therefore, by this method, 97.2% of the isolates were
distinguished from the Oka vaccine strain. This strategy will be useful in
diagnosing VZV infections induced by the vaccine strain.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region
Department of Microbiology, Asahikawa Medical College, Japan.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|